Biotechnology Stocks I Performance Guide: Amicus Therapeutics, Inc. (FOLD)
FOLD has no dividends.
Table and Chart of FOLD Performance
See what a $1,000 investment in FOLD is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| FOLD Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $2.37 |
| End Date | May-07-2024 |
| End Price | $10.42 |
| # Prices | 121 |
| Min Date | May-30-2014 |
| Min Price | $2.37 |
| Max Date | Dec-31-2020 |
| Max Price | $23.09 |
| Total Return | 339.66% |
| Annualized Return | 15.82% |
| Current Value of $1,000 Purchase | $4,397 |
| Number Returns | 7,260 |
| Average Return | 34.10% |
| Number Profitable Returns | 4,416 |
| Percent Profitable Returns | 60.83% |
| Number Unprofitable Returns | 2,844 |
| Percent Unprofitable Returns | 39.17% |
| Profitable to Unprofitable Returns Ratio | 1.55 |
| FOLD Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,071,983,000 |
| Beta | 0.756 | Price to Sales | 7.90 |
| Earnings per Share | $-0.5100 |
| PE Ratio | None |
| PE to Growth Ratio | -0.18 |
| Price to Book | 19.7 |
| PRICE DATA | |
| 52 Week High | $14.57 |
| 52 Week Low | $9.7 |
| Analyst Target Price | $18.75 |
| 50-Day Moving Average | $11.58 |
| 200-Day Moving Average | $12.14 |
| FINANCIAL DATA | |
| Revenue per Share | $1.353 |
| Revenue | $399,356,000 |
| Profit Margin | -38% |
| Return on Equity | -107% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
FOLD Compare Returns with S&P 500
FOLD Trendline Chart
FOLD Moving Average Chart
FOLD Stock Return Map - See Patterns of Gains and Losses
FOLD Stock Returns/Purchase Dates